516 related articles for article (PubMed ID: 2612809)
1. [Combination use of an automatic anti-tachycardia pacemaker and an automatic implantable cardioverter-defibrillator in sustained recurrent ventricular tachycardia resistant to drugs].
Benedini G; Caradonna E; Alfieri O; Visioli O
G Ital Cardiol; 1989 Oct; 19(10):889-900. PubMed ID: 2612809
[TBL] [Abstract][Full Text] [Related]
2. [Automatic implantable cardioverter-defibrillator (AICD) and antitachycardia pacemaker (Tachylog 651) in the treatment of ventricular tachyarrhythmias].
Gerckens U; Manz M; Funke HD; Kirchhoff PG; Lüderitz B
Z Kardiol; 1987 Apr; 76(4):211-6. PubMed ID: 3604373
[TBL] [Abstract][Full Text] [Related]
3. [Combined anti-bradycardia/anti-tachycardia pacemaker-cardioverter-defibrillator systems in patients with recurrent ventricular tachyarrhythmias].
Schmitt C; Brachmann J; Saggau W; Beyer T; Waldecker B; Scharowski K; Hilbel T; Montero M; Offner B; Schöls W
Z Kardiol; 1991 Nov; 80(11):665-72. PubMed ID: 1792808
[TBL] [Abstract][Full Text] [Related]
4. [The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker].
Cesario AS; Palermo P; Baragli D; Amici E; Biancalana G; Gambelli G; Neri R
G Ital Cardiol; 1998 Aug; 28(8):878-86. PubMed ID: 9773313
[TBL] [Abstract][Full Text] [Related]
5. [The implantable automatic cardioverter-defibrillator].
Klein H; Tröster J; Trappe HJ; Becht I; Siclari F
Herz; 1990 Apr; 15(2):111-25. PubMed ID: 2188891
[TBL] [Abstract][Full Text] [Related]
6. Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators.
Himmrich E; Przibille O; Zellerhoff C; Liebrich A; Rosocha S; Andreas K; Nebeling D; Omogbehin B; Meyer J
Circulation; 2003 Jul; 108(2):192-7. PubMed ID: 12835212
[TBL] [Abstract][Full Text] [Related]
7. Initial clinical experience with the pacemaker-cardioverter-defibrillator.
Yee R; Klein GJ; Guiraudon GM; Jones DL; Sharma AD; Norris C
Can J Cardiol; 1990 May; 6(4):147-56. PubMed ID: 2344560
[TBL] [Abstract][Full Text] [Related]
8. Termination of sustained ventricular tachycardia with a new antitachycardia pacemaker: role of the nonautomatic mode to follow pacemaker function.
Fromer M; Kus T; Page P; Shenasa M
Can J Cardiol; 1989; 5(1):42-6. PubMed ID: 2920305
[TBL] [Abstract][Full Text] [Related]
9. Nonpharmacologic therapy of ventricular tachycardia.
Josephson ME; Miller JM; Marchlinski FE; Buxton AE
Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II17-21. PubMed ID: 3271190
[TBL] [Abstract][Full Text] [Related]
10. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
Saksena S; Tullo NG; Krol RB; Mauro AM
Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
[TBL] [Abstract][Full Text] [Related]
11. Use of the automatic implantable cardioverter-defibrillator in the treatment of malignant ventricular tachyarrhythmias.
Mirowski M; Reid PR; Mower MM; Watkins L; Platia EV; Griffith LS; Juanteguy JM
Herz; 1984 Apr; 9(2):83-9. PubMed ID: 6714918
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
13. Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias.
Kay GN; Plumb VJ; Dailey SM; Epstein AE
Am J Med; 1990 Jan; 88(1N):25N-34N. PubMed ID: 2195882
[TBL] [Abstract][Full Text] [Related]
14. [Clinical assessment and indications for automatic defibrillation].
Jung W; Manz M; Lüderitz B
Ther Umsch; 1992 Aug; 49(8):580-5. PubMed ID: 1519187
[TBL] [Abstract][Full Text] [Related]
15. [Anti-tachycardia stimulation in supraventricular and ventricular tachycardia with and without cardioverter/defibrillator].
Klein H
Herz; 1991 Jun; 16(3):182-98. PubMed ID: 1889793
[TBL] [Abstract][Full Text] [Related]
16. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
Ohnishi S; Kasanuki H
J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
[TBL] [Abstract][Full Text] [Related]
17. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with the automatic implantable defibrillator.
Mirowski M; Reid PR; Mower MM; Watkins L; Platia EV; Griffith LS; Veltri EP; Guarnieri T; Juanteguy JM
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():39-42. PubMed ID: 3938257
[TBL] [Abstract][Full Text] [Related]
19. Treatment of malignant ventricular arrhythmias with endocardial resection and implantation of the automatic cardioverter-defibrillator.
Platia EV; Griffith LS; Watkins L; Mower MM; Guarnieri T; Mirowski M; Reid PR
N Engl J Med; 1986 Jan; 314(4):213-6. PubMed ID: 3941709
[TBL] [Abstract][Full Text] [Related]
20. Combination of antitachycardia pacemaker and automatic implantable cardioverter/defibrillator for ventricular tachycardia.
Manz M; Gerckens U; Funke HD; Kirchhoff PG; Lüderitz B
Pacing Clin Electrophysiol; 1986 Sep; 9(5):676-84. PubMed ID: 2429273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
